Market Cap 9.40B
Revenue (ttm) 1.61B
Net Income (ttm) 282.33M
EPS (ttm) N/A
PE Ratio 65.46
Forward PE 46.06
Profit Margin 17.53%
Debt to Equity Ratio 0.00
Volume 60,118,100
Avg Vol 73,033,039
Day's Range N/A - N/A
Shares Out 518.12M
Stochastic %K 97%
Beta 0.96
Analysts Sell
Price Target $13.60

Company Profile

UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent bui...

Industry: Software - Infrastructure
Sector: Technology
Phone: 844 432 0455
Address:
One Vanderbilt Avenue, 60th Floor, New York, United States
ELA_TRADING
ELA_TRADING Sep. 1 at 12:31 PM
$PATH I would consider the price to go up in the range of $20 - $25 in a matter of a few days or a week for a simple reason: SaaS has been under pressure for so long, re-rating is a fact and a catalyst would send this over $20 easily. Given this 2 assumptions, $PATH has everything to rise pretty fast. Paying close attention to ARR and CRPO. Expecting ARR to narrow up with revenue and +20% growth on CRPO.
1 · Reply
elprup
elprup Sep. 1 at 12:28 PM
$PATH violent down violent up 👁 will be patient
0 · Reply
DizPlinTrading
DizPlinTrading Sep. 1 at 12:08 PM
$PATH Very optimistic for their ER after hours this Thursday, but I am half anticipating some profit taking leading into it from those that are not long-term holders. It has run from $10 on July the 24th to almost $19 yesterday; there will be some traders that will look to TP before the ER. If we get a mini sell-off, it would be to the 16s in my opinion. As shown below, we are at a key resistance level so a solid beat and improved guidance, we smash through it and head higher. The ER beat is exactly the type of catalyst that can really start the move here, and it's promising that folks are buying in all month to the lead up to the date, too. Now, the total opposite could happen and we just continue the run leading into the ER. You have to also be ready for some volatility over the next 3 trading days, so do not be disheartened if we get a little pull back, consider it another buying opportunity for the long-term play 🤝
0 · Reply
elprup
elprup Sep. 1 at 11:18 AM
$PATH the standard hint some one is n trouble when every morning they go stop loss hunting and then do the reverse later to find shares to cover at higher prices… caught in your own greed!!!
0 · Reply
ClaireOrio490
ClaireOrio490 Sep. 1 at 10:49 AM
$PATH riding the automation wave and enterprise AI adoption keeps accelerating. Companies are doubling down on process automation to cut costs, and that's exactly the lane PATH plays in. Sector tailwinds look strong here. Watching this one closely.
0 · Reply
SparkleByRS
SparkleByRS Sep. 1 at 9:48 AM
$NLST look who is at the top of this 8/31/2026 SA list… https://seekingalpha.com/news/4638174-ten-information-technology-stocks-outperforming-in-august-2026?share_source=shared_news $APPN $PLTR $PATH $ZETA
0 · Reply
Carlos7144
Carlos7144 Sep. 1 at 9:41 AM
$PATH Just a little reminder of where we come from. Just 2 more days until earnings!
0 · Reply
nitzchenianu
nitzchenianu Sep. 1 at 8:30 AM
$PATH there are no RPA developer or RPA project manager jobs. if Uipath‘s clients really invested this quarter more in RPA, we would have found out by now and get invited to some interviews. which did not happen because they did not invest. NO MONEY! The party is over! Payback time now! hahahaha on Thursday ah I will pop my non alc bubbly
0 · Reply
nitzchenianu
nitzchenianu Sep. 1 at 7:48 AM
$PATH has no (working) vision. I built an agentom Uipath platform and I gave it a simple task: check a website with sports events and tell me if this team won or lost on a chosen date. failed. could not tell me accurately. not reliable at all. stop believing the donuts of drug addicts dines and his corrupt wall street. this is beyond making some money here. agentic AI is not reliable. Thursday AH payback time. Will be starting a short position on Thursday during the day. Interest rates rising so weak guidance, er will be missed on at least revenue by $25 m, no question about that. uipath clients revenues grew only 5%, their profits only 2% last year, but Uipath wants growth of 11% in q2. this is and will be a failure story because in the end results matter. drugs don’t bring results!
0 · Reply
LegUpTrade
LegUpTrade Sep. 1 at 6:59 AM
$PATH If this will get to 50$/share untill Christmas, i wont be suprised at all. I’ve seen this pattern countless times, the last one was 10x Genomics, huge volume month by month for at least 8 months and the price went from 9-10 to 65. As a joke, what 10X Genomics has in common with Uipath? Well, Cathie woods bought high and sold at 10$ 😹😹😹 then the price reversed. GLTA
1 · Reply
Latest News on PATH
UiPath price target raised to $19 from $12 at UBS

2026-08-31T10:50:24.000Z - 1 day ago

UiPath price target raised to $19 from $12 at UBS


UiPath Announces Upcoming Investor Day

Aug 25, 2026, 8:30 AM EDT - 7 days ago

UiPath Announces Upcoming Investor Day


UiPath introduces UiPath Maestro Flow orchestration canvas

2026-08-19T12:40:49.000Z - 13 days ago

UiPath introduces UiPath Maestro Flow orchestration canvas


UiPath price target raised to $15 from $12 at RBC Capital

2026-08-16T13:33:55.000Z - 15 days ago

UiPath price target raised to $15 from $12 at RBC Capital


UiPath falls -11.7%

2026-07-22T16:05:19.000Z - 5 weeks ago

UiPath falls -11.7%


UiPath price target lowered to $12 from $13 at UBS

2026-06-29T12:50:45.000Z - 2 months ago

UiPath price target lowered to $12 from $13 at UBS


UiPath Transcript: AGM 2026

Jun 25, 2026, 11:00 AM EDT - 2 months ago

UiPath Transcript: AGM 2026


UiPath announces Maestro Case capability

2026-06-16T12:36:04.000Z - 2 months ago

UiPath announces Maestro Case capability


UiPath Earnings Call Transcript: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Earnings Call Transcript: Q1 2027


UiPath Earnings release: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Earnings release: Q1 2027


UiPath Slides: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Slides: Q1 2027


UiPath Quarterly report: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Quarterly report: Q1 2027


UiPath Reports First Quarter Fiscal 2027 Financial Results

May 28, 2026, 4:10 PM EDT - 3 months ago

UiPath Reports First Quarter Fiscal 2027 Financial Results


UiPath Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 3 months ago

UiPath Proxy statement: Proxy filing


UiPath Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 4 months ago

UiPath Proxy statement: Proxy filing


UiPath Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 4 months ago

UiPath Proxy statement: Proxy filing


UiPath Transcript: Status update

Apr 6, 2026, 11:30 AM EDT - 5 months ago

UiPath Transcript: Status update


UiPath stock: why sell-off makes sense despite Q4 beat and buyback

Mar 12, 2026, 12:48 PM EDT - 6 months ago

UiPath stock: why sell-off makes sense despite Q4 beat and buyback


UiPath Earnings Call Transcript: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Earnings Call Transcript: Q4 2026


UiPath Annual report: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Annual report: Q4 2026


UiPath Earnings release: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Earnings release: Q4 2026


UiPath Slides: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Slides: Q4 2026


UiPath Annual report: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Annual report: Q4 2026


UiPath Profit, Revenue Rise as AI Adoption Spreads

Mar 11, 2026, 4:57 PM EDT - 6 months ago

UiPath Profit, Revenue Rise as AI Adoption Spreads


UiPath Transcript: 28th Annual Needham Growth Conference Virtual

Jan 13, 2026, 11:00 AM EST - 8 months ago

UiPath Transcript: 28th Annual Needham Growth Conference Virtual


ELA_TRADING
ELA_TRADING Sep. 1 at 12:31 PM
$PATH I would consider the price to go up in the range of $20 - $25 in a matter of a few days or a week for a simple reason: SaaS has been under pressure for so long, re-rating is a fact and a catalyst would send this over $20 easily. Given this 2 assumptions, $PATH has everything to rise pretty fast. Paying close attention to ARR and CRPO. Expecting ARR to narrow up with revenue and +20% growth on CRPO.
1 · Reply
elprup
elprup Sep. 1 at 12:28 PM
$PATH violent down violent up 👁 will be patient
0 · Reply
DizPlinTrading
DizPlinTrading Sep. 1 at 12:08 PM
$PATH Very optimistic for their ER after hours this Thursday, but I am half anticipating some profit taking leading into it from those that are not long-term holders. It has run from $10 on July the 24th to almost $19 yesterday; there will be some traders that will look to TP before the ER. If we get a mini sell-off, it would be to the 16s in my opinion. As shown below, we are at a key resistance level so a solid beat and improved guidance, we smash through it and head higher. The ER beat is exactly the type of catalyst that can really start the move here, and it's promising that folks are buying in all month to the lead up to the date, too. Now, the total opposite could happen and we just continue the run leading into the ER. You have to also be ready for some volatility over the next 3 trading days, so do not be disheartened if we get a little pull back, consider it another buying opportunity for the long-term play 🤝
0 · Reply
elprup
elprup Sep. 1 at 11:18 AM
$PATH the standard hint some one is n trouble when every morning they go stop loss hunting and then do the reverse later to find shares to cover at higher prices… caught in your own greed!!!
0 · Reply
ClaireOrio490
ClaireOrio490 Sep. 1 at 10:49 AM
$PATH riding the automation wave and enterprise AI adoption keeps accelerating. Companies are doubling down on process automation to cut costs, and that's exactly the lane PATH plays in. Sector tailwinds look strong here. Watching this one closely.
0 · Reply
SparkleByRS
SparkleByRS Sep. 1 at 9:48 AM
$NLST look who is at the top of this 8/31/2026 SA list… https://seekingalpha.com/news/4638174-ten-information-technology-stocks-outperforming-in-august-2026?share_source=shared_news $APPN $PLTR $PATH $ZETA
0 · Reply
Carlos7144
Carlos7144 Sep. 1 at 9:41 AM
$PATH Just a little reminder of where we come from. Just 2 more days until earnings!
0 · Reply
nitzchenianu
nitzchenianu Sep. 1 at 8:30 AM
$PATH there are no RPA developer or RPA project manager jobs. if Uipath‘s clients really invested this quarter more in RPA, we would have found out by now and get invited to some interviews. which did not happen because they did not invest. NO MONEY! The party is over! Payback time now! hahahaha on Thursday ah I will pop my non alc bubbly
0 · Reply
nitzchenianu
nitzchenianu Sep. 1 at 7:48 AM
$PATH has no (working) vision. I built an agentom Uipath platform and I gave it a simple task: check a website with sports events and tell me if this team won or lost on a chosen date. failed. could not tell me accurately. not reliable at all. stop believing the donuts of drug addicts dines and his corrupt wall street. this is beyond making some money here. agentic AI is not reliable. Thursday AH payback time. Will be starting a short position on Thursday during the day. Interest rates rising so weak guidance, er will be missed on at least revenue by $25 m, no question about that. uipath clients revenues grew only 5%, their profits only 2% last year, but Uipath wants growth of 11% in q2. this is and will be a failure story because in the end results matter. drugs don’t bring results!
0 · Reply
LegUpTrade
LegUpTrade Sep. 1 at 6:59 AM
$PATH If this will get to 50$/share untill Christmas, i wont be suprised at all. I’ve seen this pattern countless times, the last one was 10x Genomics, huge volume month by month for at least 8 months and the price went from 9-10 to 65. As a joke, what 10X Genomics has in common with Uipath? Well, Cathie woods bought high and sold at 10$ 😹😹😹 then the price reversed. GLTA
1 · Reply
bettastock
bettastock Sep. 1 at 4:52 AM
$PATH If Nvidia = Palantir, then AMD = UiPath. The valuation gap should be somewhat comparable. Nvidia is roughly 10x larger than AMD, so if Palantir commands a similar premium over UiPath, Palantir should be worth around 10x UiPath—not 100x. The current valuation gap between Palantir and UiPath looks extremely stretched. If UiPath can execute and close some of the AI/software gap, there is significant room for multiple expansion. The question isn't whether Palantir deserves a premium. It clearly does. The question is whether a 100x valuation gap versus UiPath is justified. Path at $50 billion valuation is fair value.
0 · Reply
GuNaWa
GuNaWa Sep. 1 at 3:53 AM
$PATH Short interest went up throughout 2026, now at ca 30%. Whatever happens, do not sell! Epic short squeeze is coming 🤑
1 · Reply
zipperson
zipperson Sep. 1 at 3:36 AM
$PATH It’s going to be high double digits growth! IMO
0 · Reply
elprup
elprup Sep. 1 at 2:00 AM
$PATH great numbers + raised guidance + limited willing sellers is about the strongest version of the PATH to a boom!!
0 · Reply
purple_corn
purple_corn Sep. 1 at 12:01 AM
$PATH earnings are Thur, 9/3 The stock is up +80% over the last 5 weeks and only 1 of the last 10 weeks were red. Regardless of how the stock reacts to earnings, something tells me this run is just getting started.
1 · Reply
Spicy_Trade
Spicy_Trade Aug. 31 at 11:55 PM
UiPath, Inc. ( $PATH ) SpicyTrade - Daily Stock Analysis https://youtu.be/zaWae7WIF9A?si=69PRtYxrrbRhayA4
0 · Reply
gentleowl
gentleowl Aug. 31 at 10:21 PM
0 · Reply
LMSS
LMSS Aug. 31 at 10:08 PM
$PATH $25 Then $50 Then $75 Then $100
3 · Reply
Quaidstartthereactor
Quaidstartthereactor Aug. 31 at 9:32 PM
$PATH this is showing some crazy strength.
1 · Reply
IdeletedRobinhood
IdeletedRobinhood Aug. 31 at 9:24 PM
$PATH Funny how Cathie Wood bought 12M shares at IPO ($73.33), another 12M at $60 and continued to add down to $17 Then exited PATH completely at $11.99 Cathie Wood is a one-hit-wonder when it comes to institutional investors in my opinion She had a great call on Tesla, then had some other runs which followed during the Covid rally (when everyone was an “expert” and making money), and now would probably be bankrupt if it weren’t for the fact she invests other people’s money Kind of irritating how, since I bought in May, whenever I mentioned UiPath to people IRL they’d say “Oh, that’s the Cathie Wood stock right?” No, this is not a “Cathie Wood stock” First of all she’s kind of an idiot - and second of all she sold all her PATH at essentially the bottom over a year ago Looking forward to re-emerging from the ashes without being pumped by or associated with a degenerate grandma 🍻📈
6 · Reply
DizPlinTrading
DizPlinTrading Aug. 31 at 9:16 PM
$PATH What a day, and a fantastic end to August! Delighted! September will be even better 🤝
1 · Reply
zipperson
zipperson Aug. 31 at 8:21 PM
$PATH Significant accumulation in the last quarter. Shorts are trapped!
2 · Reply